TRAK vs. PHR, DFIN, CRTO, GDRX, GB, TASK, OLO, NVEE, UPBD, and ASTH
Should you be buying Repositrak stock or one of its competitors? The main competitors of Repositrak include Phreesia (PHR), Donnelley Financial Solutions (DFIN), Criteo (CRTO), GoodRx (GDRX), Global Blue Group (GB), TaskUs (TASK), OLO (OLO), NV5 Global (NVEE), Upbound Group (UPBD), and Astrana Health (ASTH). These companies are all part of the "business services" industry.
Repositrak vs. Its Competitors
Repositrak (NYSE:TRAK) and Phreesia (NYSE:PHR) are both small-cap services companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations.
Repositrak has a net margin of 0.00% compared to Phreesia's net margin of -20.43%. Repositrak's return on equity of 0.00% beat Phreesia's return on equity.
In the previous week, Repositrak and Repositrak both had 11 articles in the media. Repositrak's average media sentiment score of 0.54 beat Phreesia's score of 0.54 indicating that Repositrak is being referred to more favorably in the media.
27.4% of Repositrak shares are owned by institutional investors. Comparatively, 92.1% of Phreesia shares are owned by institutional investors. 44.0% of Repositrak shares are owned by insiders. Comparatively, 5.5% of Phreesia shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Phreesia has a consensus target price of $31.64, suggesting a potential upside of 18.93%. Given Phreesia's stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than Repositrak.
Phreesia received 154 more outperform votes than Repositrak when rated by MarketBeat users. However, 100.00% of users gave Repositrak an outperform vote while only 68.89% of users gave Phreesia an outperform vote.
Repositrak has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Comparatively, Phreesia has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.
Repositrak has higher earnings, but lower revenue than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than Repositrak, indicating that it is currently the more affordable of the two stocks.
Summary
Repositrak beats Phreesia on 10 of the 17 factors compared between the two stocks.
Get Repositrak News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRAK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TRAK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Repositrak Competitors List
Related Companies and Tools
This page (NYSE:TRAK) was last updated on 6/13/2025 by MarketBeat.com Staff
